ReviewTranslational lung cancer research2017

Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: the necessity of repeated molecular analysis.

José Luís González-Larriba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.